Clinical trial
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis: Comparison of Infusion Every 6 Weeks Versus Infusion on Demand
NCT00439283 is registered in ClinicalTrials.gov with Association de Recherche Clinique en Rhumatologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis: Comparison of Infusion Every 6 Weeks Versus Infusion on Demand
- Lead sponsor
- Association de Recherche Clinique en Rhumatologie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2003
- Completion date
- December 31, 2004
- Enrollment
- 240
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis